Clinical trial · Interventional
Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.
NCT03541330CI-TRIAL-00098821terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): default of inclusion
Summary
Brief summary (as posted)
The primary objective is to evaluate the experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy at the Centre Hospitalier Régional et Universitaire of Lille
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Haemopathy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| semi-directive interview | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- siblings
- description
- Brother or sister of a child has malignant haemopathy and follow-up in the pediatric hematology department
- interventionNames
- Other: semi-directive interview
Primary outcomes (1)
- measure
- Level of satisfaction and characteristics of information received about the disease by healthy siblings of children with hematological malignancies
- timeFrame
- 1 year
- description
- Measure Qualitative Interviews by Grounded theory. The experience with the information received on the disease by the healthy brothers and sisters of childrens with malignant haemopathy. Assessment of the level of satisfaction with the information received. The information will be characterized according to three dimensions: the framework (by whom, with whom, where, when, how) and the content of the information
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 6 Years
- Maximum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * Children from 6 to 12 years old * Brother or sister of a child: O has malignant haemopathy O follow-up in the pediatric hematology department in Lille, O diagnosed from 6 weeks to 1 year before maintenance of the healthy subject included * whose parents are able to understand and sign voluntarily informed consent * Affiliated to a social security scheme * Ability to understand and answer questions alone during the semi-structured interview Exclusion Criteria: * Child under 6 years or over 12 years * Subject with a pathology that may interfere with the course of the study, according to the investigator's assessment * Absence of the informed consent of one of the parents and / or the legal representative * Refusal of participation of the subject
References
Publications (0)
Data not yet available
No reference posted for this study.